Abbott Laboratories (ABT)
117.71
+0.06
(+0.05%)
USD |
NYSE |
Nov 05, 16:00
117.71
0.00 (0.00%)
After-Hours: 16:06
Abbott Laboratories Cash from Financing (Quarterly): -1.576B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.576B |
| June 30, 2024 | -791.00M |
| March 31, 2024 | -1.176B |
| December 31, 2023 | -2.052B |
| September 30, 2023 | -2.34B |
| June 30, 2023 | -1.289B |
| March 31, 2023 | -1.41B |
| December 31, 2022 | -1.457B |
| September 30, 2022 | -1.543B |
| June 30, 2022 | -813.00M |
| March 31, 2022 | -3.823B |
| December 31, 2021 | -1.886B |
| September 30, 2021 | -1.377B |
| June 30, 2021 | -1.264B |
| March 31, 2021 | -967.00M |
| December 31, 2020 | -787.00M |
| September 30, 2020 | -1.915B |
| June 30, 2020 | 658.00M |
| March 31, 2020 | -735.00M |
| December 31, 2019 | -2.185B |
| September 30, 2019 | -513.00M |
| June 30, 2019 | -449.00M |
| March 31, 2019 | -1.142B |
| December 31, 2018 | -4.776B |
| September 30, 2018 | 2.471B |
| Date | Value |
|---|---|
| June 30, 2018 | -1.631B |
| March 31, 2018 | -6.455B |
| December 31, 2017 | -112.00M |
| September 30, 2017 | -386.00M |
| June 30, 2017 | -384.00M |
| March 31, 2017 | -4.399B |
| December 31, 2016 | 13.50B |
| September 30, 2016 | -746.00M |
| June 30, 2016 | -179.00M |
| March 31, 2016 | -1.432B |
| December 31, 2015 | -497.00M |
| September 30, 2015 | -815.00M |
| June 30, 2015 | -374.00M |
| March 31, 2015 | -550.00M |
| December 31, 2014 | -700.00M |
| September 30, 2014 | -271.00M |
| June 30, 2014 | -619.00M |
| March 31, 2014 | -1.152B |
| December 31, 2013 | -1.869B |
| September 30, 2013 | -559.00M |
| June 30, 2013 | 465.00M |
| March 31, 2013 | -4.733B |
| December 31, 2012 | 2.505B |
| September 30, 2012 | -2.591B |
| June 30, 2012 | 115.37M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.823B
Minimum
Mar 2022
658.00M
Maximum
Jun 2020
-1.436B
Average
-1.394B
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Becton Dickinson & Co | 1.119B |
| ResMed Inc | -150.76M |
| Integra Lifesciences Holdings Corp | -93.75M |
| QuidelOrtho Corp | 162.50M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.705B |
| Cash from Investing (Quarterly) | -594.00M |
| Free Cash Flow | 6.486B |
| Free Cash Flow Per Share (Quarterly) | 1.230 |
| Free Cash Flow to Equity (Quarterly) | 1.924B |
| Free Cash Flow to Firm (Quarterly) | 2.192B |
| Free Cash Flow Yield | 3.15% |